To supply Anti-Malaria Drugs for CHAI
Dr.Datsons Labs announced that the Company has received a proposal to supply the Artemisinin-based combination therapies (ACTs) on a discounted price to The Clinton Health Access Initiative (CHAI), the healthcare project of the Clinton Foundation.Powered by Capital Market - Live News
